💊 The biotech Wall Street just woke up to ($DNTH)

Copy My Trades | Reviews | Trade With Me

Good Morning!

Let me be straight with you.

$50 USDT. Free. Just for signing up.

That's not a typo. That's not a "up to" figure buried in the small print. That's cash in your account before you do anything else.

And it doesn't stop there:

💵 $50 USDT - free on sign up, no strings 📈 20% matched on your first deposit - up to $750 USDT back in your pocket 🎟️ 2 free La Liga tickets - yes, actual football tickets, on top of everything else

That's $800 in value before you place a single trade.

Last week I ran this and half of you left $800 on the table. I'm not letting that happen again - so this week I'm making it simple: 30 spots. That's it. When they're gone, the link dies. No extensions. No DMs. No exceptions.

Toobit is non-KYC, Bybit-backed, and takes 3 minutes to set up. There is genuinely no work involved here - just free money for being part of this community.

The people who clicked last week already have their $50. The question is whether you're going to be the one explaining next week why you didn't.

👉 Claim your $50 + up to $800 in bonuses now

⏳ 30 spots remaining. Link closes when they're gone - and this time I mean it.

🌡 TradingLab’s Headline Roundup

The number everyone's been dreading just landed.

Goldman Sachs forecast a 0.87% rise in March headline CPI, implying a jump in year-over-year inflation from 2.43% to 3.28% - and warns energy prices are likely to spike again in April, potentially taking headline CPI to around 4%.

That's the Iran war showing up directly in your cost of living - and the Fed's. Markets have already effectively priced out any rate cuts, and a hotter-than-expected print could force the Fed to maintain or raise rates.

Meanwhile the ceasefire is holding by a thread: reports of US-Iran talks in Pakistan were denied by Iranian media, highlighting conflicting signals and keeping uncertainty high despite the fragile truce.

Stocks are pushing higher regardless - S&P 500 up 0.52%, Dow up 0.66%, Bitcoin sitting near $72K - but this rally is one bad headline away from unravelling.

The market wants to believe the war is over. The data says the damage is just starting to show up.

🏛️ Stock Markets

March CPI just dropped - and it's ugly - Inflation is estimated to have jumped to 3.3% year-over-year in March, the highest since May 2024 and a sharp acceleration from 2.4% in February, driven by the Iran war's energy shock and tariff pass-through. The "inflation is under control" crowd is going to need a new script.
Fed officials are now openly talking about rate hikes - A growing number of Fed officials are considering the possibility of a rate hike, according to minutes of their latest meeting. Rate cuts in 2026? Dead. Hikes? On the table. This market is not priced for that.
Goldman: Brent stays above $100 if Hormuz stays shut another month - Goldman Sachs calculates that Brent crude would average more than $100 a barrel through 2026 if the Strait of Hormuz remains closed for another month. Their base case assumes flows begin recovering this weekend - but they flag risks are "skewed to the upside." One weekend of failed diplomacy changes everything.
S&P extends winning streak - but don't get too excited - The S&P 500 rose 0.6%, the Nasdaq climbed 0.8%, and the Dow added 276 points Thursday - pushing the blue-chip index into positive territory for 2026. Peace talks this weekend in Islamabad. Markets are pricing a deal. Iran's parliament speaker called negotiations "unreasonable." Draw your own conclusions.
FedEx pilots get their 40% raise - and the whole logistics sector just got more expensive - FedEx and the Air Line Pilots Association reached a tentative agreement featuring a 40% hourly wage increase in 2026, followed by 3% annual raises through 2030, and up to $150,000 in retroactive pay for senior captains. UPS, airlines, every logistics name - structurally higher cost bases. This isn't a one-off.
Meta up on $21B CoreWeave AI deal - CoreWeave announced an expanded, long-term agreement to provide AI cloud capacity for Meta through December 2032, valued at about $21 billion. AI infrastructure spend is not slowing. Follow the capex.
Disney cutting 1,000 jobs as new CEO sharpens the knife - Disney plans up to 1,000 layoffs, largely in marketing, as new CEO Josh D'Amaro accelerates cost-cutting. "Efficiency" season is back in Hollywood.
US housing market cracks under $4 gas and 6.4% mortgages - Contract signings fell 2.4% year-over-year in the four weeks through April 5 - the worst decline in three months - and new listings dropped 2.6% in the same period. Rates fell below 6% in February. The war killed it. They're back at 6.4%.

₿ Crypto

Bitcoin back above $71K - but the macro ceiling is real - BTC has lost about 23% from its January price of $87,500, marking its first back-to-back quarterly losses since 2022. The ceasefire bounce is helping. The "higher for longer + possible hike" narrative is not. Pick your poison.
Fear & Greed sitting at 11 - Extreme Fear - The Fear & Greed Index is displaying a score of 11, deep in Extreme Fear territory. Historically, that's when people who bought are rewarded. Historically. Context matters right now.
CLARITY Act crypto regulation markup coming late April - The CLARITY Act markup in late April is flagged as a key catalyst that could move the crypto market materially. The one policy event worth watching in a sea of geopolitical noise.

🔓 FREE PREVIEW: These alerts are delayed. Upgrade to access them in real-time and join my trading community.

The Play

Mr. M is eyeing $DNTH as a swing trade opportunity at current levels, with a clear risk-defined structure.

Entry: $90.30
Targets: $92 → $94 → $97 → $100 → $107+
Stop Loss: $84.70
ATR: 4.71

The Catalyst

Raymond James recently upgraded DNTH from Outperform to Strong Buy, slamming a $123 price target on it - nearly double their previous $63 target. HC Wainwright followed with a $130 price target and a Buy rating, with TD Cowen also reiterating their Buy. Markets Daily That's a wall of institutional conviction hitting at the same time. The company also closed a heavily upsized $719 million public offering in March Stock Titan - meaning the balance sheet is stacked and the runway is clear. Phase 3 trials for their lead candidate DNTH103 are set to kick off mid-2026, targeting chronic inflammatory demyelinating polyneuropathy and other severe autoimmune conditions. The Motley Fool The pipeline is moving, the money is in the bank, and Wall Street is just waking up to it.

Our Take

This is a well-funded biotech with serious analyst tailwinds and a Phase 3 catalyst on the horizon - that's a setup worth paying attention to. The stock has come a long way from its 52-week lows, but with price targets ranging from $123 to $130 and fresh institutional upgrades, there's still meaningful upside from here if the thesis plays out. The $84.70 stop keeps the risk clean and well-defined. Scale into targets, don't get greedy at $92, and keep an eye on any Phase 3 trial updates - that's where the real fireworks will come from.

Trades like this land in our community before they move. If you're not already inside, you're already behind - join TradingLab here and get Mr. M's setups the moment they drop.